Effect of combination of rapamycin and cisplatin on human cervical carcinoma
Hela cells

Lu Han; Jie-Ling Wu; Li-Xiao Yang

doi:10.5114/wo.2012.32483

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

6/2012
vol. 16

Send email

Copy url:

abstract:

Original paper

Effect of combination of rapamycin and cisplatin on human cervical carcinoma Hela cells

Lu Han

,

Jie-Ling Wu

,

Li-Xiao Yang

Wspolczesna Onkol 2012; 16 (6): 512–515

DOI: https://doi.org/10.5114/wo.2012.32483

Online publish date: 2013/01/04

View full text Get citation

PlumX metrics:

Aim of the study: To evaluate the effect of combined use of rapamycin and cisplatin against Hela cells in vitro.

Material and methods: The inhibitory effects of rapamycin and cisplatin, used alone or combination, on the proliferation of Hela cell were measured with MTT assay and median-effect plot analysis.

Results: Combined use of rapamycin and cisplatin significantly improved the chemotherapeutic effect against Hela cells. The inhibitory rates were dose-dependent. Rapamycin and cisplatin showed synergistic effects in the chemotherapy of Hela cells (q > 1.15, King’s formula).

Conclusions: Combined use of rapamycin and cisplatin significantly improves the chemotherapeutic effect against Hela cells.

keywords:

Effect of combination of rapamycin and cisplatin on human cervical carcinoma Hela cells

Lu Han , Jie-Ling Wu , Li-Xiao Yang

rapamycin, cisplatin, cervical carcinoma, Hela cells

Lu Han

,

Jie-Ling Wu

,

Li-Xiao Yang